The Gates Biomanufacturing Facility at the University of Colorado Anschutz Medical Campus is a 20,000 square ft. GMP compliant facility that provides cell-based therapies and protein biologics for use in preclinical investigations and Phase I and Phase II human clinical trials. The GBF was established in 2015 through partnership with the Gates Center for Regenerative Medicine, University of Colorado Health, Children's Hospital Colorado, University of Colorado-School of Medicine, and the Gates Frontiers Fund.